EUVIMEDEUVIMED entdecken
Crossref

Synthesis and HDAC1 Inhibitory Activity of a Novel Series of Coumarin-Based Amide Derivatives for Treatment of Cancer

Sharba Tasneem, M Mumtaz Alam iD, Suhel Parvez iD, Pinky, Farah Khan iD, Manika Garg, Mohd Amir, Mymoona Akhter iD, Shaista Amin iD, Mohammad Ahmed Khan iD, Mohammad Shaquiquzzaman iD

Future Medicinal Chemistry · 2023

DOI: 10.4155/fmc-2023-0105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2023. Verfasst von Sharba Tasneem und 10 weiteren Autor:innen. Beteiligte Einrichtung: Drug Design & Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delh…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsAmidesCoumarinsEpigenesis, GeneticCell Line, TumorHistone Deacetylase InhibitorsCell ProliferationHydroxamic AcidsDrug DesignStructure-Activity RelationshipDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

HDAC1TNF-αanticancercinnamidecoumarindocking

Substanzen

AmidesCoumarinsHistone Deacetylase InhibitorsHydroxamic AcidsAntineoplastic Agents

Autor:innen und Institutionen

  • Drug Design & Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, 110062, India.
  • Department of Elementology & Toxicology, School of Chemical & Life Sciences, Jamia Hamdard, New Delhi, 110062, India.
  • Department of Biochemistry, School of Chemical & Life Sciences, Jamia Hamdard, New Delhi, 110062, India.
  • Department of Pharmacology, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, 110062, India.

ORCID-Profile: M Mumtaz Alam, Suhel Parvez, Farah Khan, Mymoona Akhter, Shaista Amin, Mohammad Ahmed Khan, Mohammad Shaquiquzzaman

Förderung

  • Department of Science and Technology, Ministry of Science and Technology, India

Zitieren

APA

Tasneem, S., Alam, M. M., Parvez, S., Pinky, Khan, F., Garg, M., Amir, M., Akhter, M., Amin, S., Khan, M. A., & Shaquiquzzaman, M. (2023). Synthesis and HDAC1 Inhibitory Activity of a Novel Series of Coumarin-Based Amide Derivatives for Treatment of Cancer. Future Medicinal Chemistry. https://doi.org/10.4155/fmc-2023-0105

Vancouver

Tasneem S, Alam MM, Parvez S, Pinky, Khan F, Garg M, et al. Synthesis and HDAC1 Inhibitory Activity of a Novel Series of Coumarin-Based Amide Derivatives for Treatment of Cancer. Future Medicinal Chemistry. 2023. doi:10.4155/fmc-2023-0105

BibTeX
@article{Tasneem2023,
  author = {Tasneem, Sharba and Alam, M Mumtaz and Parvez, Suhel and Pinky and Khan, Farah and Garg, Manika and Amir, Mohd and Akhter, Mymoona and Amin, Shaista and Khan, Mohammad Ahmed and Shaquiquzzaman, Mohammad},
  title = {Synthesis and HDAC1 Inhibitory Activity of a Novel Series of Coumarin-Based Amide Derivatives for Treatment of Cancer},
  journal = {Future Medicinal Chemistry},
  year = {2023},
  doi = {10.4155/fmc-2023-0105}
}
Kostenlos starten →